FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Guide on Oncologic Drug Dose Optimization

Federal Register notice: FDA makes available a final guidance entitled Optimizing the Dosage of Human Prescription Drugs and Biological Products for t...

latest-news-card-1
Federal Register

Guide BCG-Unresponsive Bladder Cancer Drugs

Federal Register notice: FDA makes available a draft guidance entitled Bacillus Calmette-Gurin-Unresponsive Nonmuscle Invasive Bladder Cancer: Develop...

latest-news-card-1
Human Drugs

Hold Lifted on Fabry Cardiomyopathy Therapy

FDA lifts a clinical hold against 4D Molecular Therapeutics 4D-310 therapy being studied for treating Fabry disease cardiomyopathy.

latest-news-card-1
Federal Register

Panel to Mull Clozapine REMS Potential Changes

Federal Register notice: FDA announces an 11/19 advisory committee meeting to discuss potential changes to the clozapine risk evaluation and mitigatio...

latest-news-card-1
Human Drugs

FDA OKs Neffy Allergic Reaction Nasal Spray

FDA approves an ARS Pharmaceuticals NDA for neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions.

latest-news-card-1
Human Drugs

Braun Recalls 2 Sodium Chloride Lots

Braun Medical recalls (Class 1) two lots of 0.9% sodium chloride for injection USP 1,000 mL due to the potential for particulate matter in the drug co...

latest-news-card-1
Medical Devices

Cardiologist to Lead Digital Health Panel

FDA selects American College of Cardiology chief innovation officer Ami Bhatt to serve a four-year term as chair of the agencys recently created Digit...

latest-news-card-1
Human Drugs

BCG Treatment Development Guidance

FDA publishes a draft guidance on developing drug and biological treatments for a specific bladder cancer.

latest-news-card-1
Human Drugs

FDA OKs Cutaneous T-cell Lymphoma Therapy

FDA approves a Citius Pharmaceuticals BLA for Lymphir (denileukin diftitox-cxdl) for treating relapsed or refractory cutaneous T-cell lymphoma.

latest-news-card-1
Human Drugs

Purdues Opioid-Reversing Injector Approved

FDA approves a Purdue Pharma NDA for Zurnai, a nalmefene hydrochloride auto-injector for the emergency treatment of known or suspected opioid overdose...